0 works0 citations0 h-index

Cecilia A. Vasquez

Publications by Year

Research Areas

Ubiquitin and proteasome pathways, Signaling Pathways in Disease, Glycosylation and Glycoproteins Research, CAR-T cell therapy research, Immunotherapy and Immune Responses

Most-Cited Works

→ Preferential Expression of Very Late Antigen-4 on Type 1 CTL Cells Plays a Critical Role in Trafficking into Central Nervous System Tumors(2007)71 cited
→ Heat Shock Protein 90 Inhibitor 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin Enhances EphA2+ Tumor Cell Recognition by Specific CD8+ T Cells(2009)38 cited
→ Enhancement in Specific CD8+ T Cell Recognition of EphA2+ Tumors In Vitro and In Vivo after Treatment with Ligand Agonists(2008)27 cited
→ Exploring Veterinary Medicine Students’ Experiences with Team-Based Learning at the Universidad Andrés Bello(2019)3 cited
→ Supplementary Figure 4 from Heat Shock Protein 90 Inhibitor 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin Enhances EphA2+ Tumor Cell Recognition by Specific CD8+ T Cells(2023)
→ Supplementary Figure 3 from Heat Shock Protein 90 Inhibitor 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin Enhances EphA2+ Tumor Cell Recognition by Specific CD8+ T Cells(2023)
→ Supplementary Figure 1 from Heat Shock Protein 90 Inhibitor 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin Enhances EphA2+ Tumor Cell Recognition by Specific CD8+ T Cells(2023)
→ Data from Preferential Expression of Very Late Antigen-4 on Type 1 CTL Cells Plays a Critical Role in Trafficking into Central Nervous System Tumors(2023)
→ Supplementary Figure 2 from Heat Shock Protein 90 Inhibitor 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin Enhances EphA2+ Tumor Cell Recognition by Specific CD8+ T Cells(2023)
→ HSP90 inhibitor 17-DMAG enhances EphA2+ tumor cell recognition by specific CD8+ T cells (40.27)(2009)